| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150840 Detection and Treatment of Glyco-Enzyme-Related Disease |
| 06/22/2011 | EP2336370A2 Recombinant Newcastle disease virus RNA expression systems and vaccines |
| 06/22/2011 | EP2336368A1 Endogenous retroviruses up-regulated in prostate cancer |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336319A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336318A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336166A1 Compositions that inhibit proliferation of cancer cells |
| 06/22/2011 | EP2336145A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2335738A1 Stem-cell, precursor cell or target cell-based treatment of wound healing |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335724A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2335723A1 Immunisation against chlamydia trachomatis |
| 06/22/2011 | EP2334794A2 Modulation of bcl11a for treatment of hemoglobinopathies |
| 06/22/2011 | EP2334791A1 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 06/22/2011 | EP2334789A1 Breast cancer related gene rqcd1 |
| 06/22/2011 | EP2334379A2 Host cell kinases as targets for antiviral therapies against hcv infection |
| 06/22/2011 | EP2334339A2 Diagnostic, prognostic and therapeutic uses of mirs in adaptive pathways and/or disease pathways |
| 06/22/2011 | EP1817348B1 Per-6-guanidino-, -aminoalkylamino-and -guanidino-alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of dna and intracellular delivery |
| 06/22/2011 | EP1619951B1 Methods and compositions for treating disorders |
| 06/22/2011 | EP1556402B1 In vivo gene silencing by chemically modified and stable sirna |
| 06/22/2011 | EP1546174B1 Methods and compositions for rna interference |
| 06/22/2011 | EP1328545B1 Human gene critical to fertility |
| 06/22/2011 | EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 06/22/2011 | CN1981040B Recombinant virus vector for gene introduction in lymphocyte |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN1384885B Preparation method of recombinant adenoviruses and adenovirus banks |
| 06/22/2011 | CN102102102A Novel application of hsa-miR-185 |
| 06/22/2011 | CN102102101A SiRNA for inhibiting expression of Plk1 and use thereof |
| 06/22/2011 | CN102100916A Freeze-drying liposome and preparation method and application thereof |
| 06/22/2011 | CN101575602B siRNA sequence for inhibiting human BFGF gene expression amplification and expression carrier and application thereof |
| 06/22/2011 | CN101455846B Tuberculosis gene vaccine assembled by chitosan delivery system and preparation method and use thereof |
| 06/22/2011 | CN101270168B Hyaluronic acid stem grafting polyethylene imine copolymer, preparing method and application as genophore |
| 06/22/2011 | CN101265484B Method for constructing pacing channel gene hypotype HCN2 recombination slow virus vector |
| 06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
| 06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964579 Compositions and methods for topical delivery of oligonucleotides |
| 06/21/2011 | US7964576 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 06/21/2011 | US7964574 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 06/21/2011 | US7964572 High affinity nucleic acid ligands of complement system proteins |
| 06/21/2011 | US7964571 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 06/21/2011 | US7964570 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 06/21/2011 | US7964555 Contacting cardiac muscle cells with a neuregulin protein to activate the MAP kinase pathway in cardiac muscle cells and induce remodeling of cardiac muscle cell sarcomeric and cytoskeleton structures or cell-cell adhesions |
| 06/21/2011 | US7964394 Spore-like cells and uses thereof |
| 06/21/2011 | US7964367 Human p51 genes and gene products thereof |
| 06/21/2011 | US7964206 Porous medical device and method for its manufacture |
| 06/21/2011 | US7964192 Prevention and treatment of amyloidgenic disease |
| 06/21/2011 | US7964190 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 06/21/2011 | US7964185 Apicomplex vaccine strains of a family of Sarcocystidae |
| 06/21/2011 | CA2505786C Methods for identifying risk of breast cancer and treatments thereof |
| 06/21/2011 | CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/21/2011 | CA2342770C Ly6h gene |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 06/21/2011 | CA2286177C Composition for gene transfer into cells |
| 06/21/2011 | CA2258735C Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus |
| 06/21/2011 | CA2203857C Microparticles for delivery of nucleic acid |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/16/2011 | WO2011072247A2 Pathogen restriction factors |
| 06/16/2011 | WO2011072082A2 Modulation of hsp47 expression |
| 06/16/2011 | WO2011071860A2 Compositions for nucleic acid delivery |
| 06/16/2011 | WO2011071859A1 Method and composition to increase radiation-induced tumor therapeutic effects |
| 06/16/2011 | WO2011071632A2 Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics |
| 06/16/2011 | WO2011071078A1 Aromatic compound, modification carrier that uses same and is used for synthesizing an oligonucleotide derivative, oligonucleotide derivative, and oligonucleotide construct |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011071027A1 Rna interference molecule capable of inhibiting expression of socs3 protein encoded by socs3 gene, and use thereof |
| 06/16/2011 | WO2011069587A1 Lyophilization of nucleic acids in lactate-containing solutions |
| 06/16/2011 | WO2011069528A1 Lyophilization of nucleic acids in lactate-containing solutions |
| 06/16/2011 | WO2011069335A1 Use of pyridines compounds in preparing rna interference reinforcing agent |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144187 Aptamer inhibition of thrombus formation |
| 06/16/2011 | US20110144004 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 06/16/2011 | US20110143424 Recombinant influenza viruses for vaccines and gene therapy |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142913 Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug |
| 06/16/2011 | US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 06/16/2011 | US20110142879 Infectious clones |
| 06/16/2011 | US20110142872 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/16/2011 | US20110142871 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | US20110142839 Treatment of pulmonary edema |
| 06/16/2011 | US20110142811 Measles virus for the elimination of unwanted cell populations |
| 06/16/2011 | US20110142763 Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues |
| 06/16/2011 | DE102004037652B4 Verfahren zur Modulation der Genexpression durch Änderung des CpG Gehalts Process for the modulation of gene expression by changing the CpG content |
| 06/16/2011 | CA2783876A1 New conjugates and compositions for immunotherapy and antitumoral treatment |
| 06/16/2011 | CA2783010A1 Method and composition to increase radiation-induced tumor therapeutic effects |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |